Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma: Short-term Follow-up of Anatomical and Functional Responses

NCT03973125 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT03973125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03973125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Intravitreal Conbercept Injection as a Primary Treatment for Exudative Circumscribed Choroidal Haemangioma: Short-term Follow-up of Anatomical and Functional Responses
Lead sponsor
Sun Yat-sen University
Phase
Phase 1
Overall status
Unknown status
Start date
August 28, 2014
Completion date
January 1, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circumscribed choroidal haemangioma